s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
8-K
Current report filing
Filed
Thursday, August 6, 2026
Period
Aug 6, 2026
Accession number
0001171843-26-005292
Documents
FORM 8-K
8-K
PRESS RELEASE
EX-99.1
XBRL SCHEMA FILE
EX-101.SCH
XBRL DEFINITION FILE
EX-101.DEF
XBRL LABEL FILE
EX-101.LAB
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header